NewGenIvf Group Limited Class A Company Profile
NASDAQ: NIVFHealth CareMisc Health and Biotechnology ServicesUSD
Market open · Delayed 15 min · as of Oct 9, 11:23 AM ET
NewGenIvf Group at a glance
NewGenIvf Group Limited Class A (NASDAQ: NIVF) is a Misc Health and Biotechnology Services company in the Health Care sector headquartered in Bangkok, Singapore. NewGenIvf Group is led by Mr. Wing Fung Siu and employs about 87 people. At a market capitalization of $2.2 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001981662, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does NewGenIvf Group do?
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Business description based on the company's public filings.
Company information
- Legal name
- NewGenIvf Group Limited Class A
- Ticker
- NASDAQ: NIVF
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Mr. Wing Fung Siu
- Employees
- 87
- Headquarters
- PS Tower,36/39-36/40, Bangkok, Singapore
- Website
- nivf.global
- Market cap
- $2.21M
- SEC CIK
- 0001981662
Companies similar to NewGenIvf Group
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MGRXMangoceuticals Inc. | 0.4393 | +1.60% | $9.47M | vs NIVF |
| CCELCryo-Cell International Inc. | 4.00 | -4.08% | $32.25M | vs NIVF |
| PARKPark Dental Partners Inc. | 20.00 | -2.91% | $95.11M | vs NIVF |
| VMDViemed Healthcare Inc. | 9.45 | +0.43% | $359.93M | vs NIVF |
| AGLagilon health inc. | 84.00 | -0.85% | $1.41B | vs NIVF |
| PGNYProgyny Inc. | 27.72 | -0.40% | $2.13B | vs NIVF |
| SHCSotera Health Company | 18.06 | +1.29% | $5.15B | vs NIVF |
| FMSFresenius Medical Care AG ADR | 21.06 | +0.84% | $11.21B | vs NIVF |